Home
E-Submission
Sitemap
Contact Us
ABOUT
Aims and scope
About the journal
Editorial board
Best practice
Open access
Contact us
BROWSE ARTICLES
All issues
Current issue
Most read articles
Most download articles
Most cited articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Advertising policy
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article processing charge
Readership
E-submission
Search
Search
Page Path
HOME
Search
Case Report
Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis
Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim
J Mult Scler Neuroimmunol.
2024;15(1):31-34. Published online June 30, 2024
DOI:
https://doi.org/10.59578/jmsni.2024.15.1.31
Full text
PubReader
ePub
PDF
Review Article
Rituximab Treatment for Neuroimmunologic Disorders
Ilhan Yoo
J Mult Scler Neuroimmunol.
2023;14(1):44-50. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.44
Full text
PubReader
ePub
PDF
Review Article
Monoclonal Antibody Therapies for Neuromyelitis Optica Spectrum Disorder
Woojun Kim
J Mult Scler Neuroimmunol.
2023;14(1):15-23. Published online June 30, 2023
DOI:
https://doi.org/10.59578/jmsni.2023.14.1.15
Full text
PubReader
ePub
PDF
Case Report
Favorable Response to Rituximab in a Patient with Recurrent Primary Angiitis of the Central Nervous System: A Case Report and Literature Review
Tae Young Kim, Yong Jin Kim, Min Kim, Jae Hyun Jeon, Hyun-Mi Park, Dong Hoon Shin, Jiwon Yang
J Mult Scler Neuroimmunol.
2022;13(2):30-34. Published online December 31, 2022
PDF
Case Report
Successful Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Rituximab
Dayoung Kim, Kyomin Choi, Jeeyoung Oh
J Mult Scler Neuroimmunol.
2021;12(2):39-42. Published online December 1, 2021
PDF
Case Report
Delayed Hepatitis B Reactivation after Repeated Rituximab Treatments for Neuromyelitis Optica Spectrum Disorder
Hyesun Lee, Euihyun Sung, Wonjae Sung, Seung Hyun Kim
J Mult Scler Neuroimmunol.
2021;12(2):35-38. Published online December 1, 2021
PDF
Case Report
Steroid-Unresponsive Immune-Mediated Necrotizing Myopathy Successfully Treated with Rituximab
Jong-Su Kim, SeonDeuk Kim, Woohee Ju, Soo Hyun Park, Je-Young Shin, Jung-Joon Sung, Seok-Jin Choi
J Mult Scler Neuroimmunol.
2021;12(1):1-5. Published online January 1, 2021
PDF
Case Report
Cost Effectiveness of First-Line Rituximab in Koreans with Neuromyelitis Optica Spectrum Disorder
Jae-Won Hyun, Hyunmin Jang, Jeongmi Park, Min Young Lee, Su-Hyun Kim, Ho Jin Kim
J Mult Scler Neuroimmunol.
2020;11(2):53-58. Published online December 1, 2020
PDF
Review Article
Rituximab for the Treatment of Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim
J Mult Scler Neuroimmunol.
2017;8(1):1-8. Published online March 1, 2017
PDF
Case Report
Successful Treatment of Neuromyelitis Optica with Rituximab
Hyun Du Noh, Min Su Park
J Mult Scler Neuroimmunol.
2010;1(2):59-63. Published online September 1, 2010
PDF
1
Journal of Multiple
Sclerosis and
Neuroimmunology
Print ISSN: 2733-8290
Online ISSN: 2951-2972
MOST VIEWED
MOST CITED
6,015
Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,666
Rituximab Treatment for Neuroimmunologic Disorders
2,372
National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,334
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,216
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
+more
Cited By
2
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
+more